Degirolamo, Chiara

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

Degirolamo, C., Sabbà, C., & Moschetta, A. (2016) · Nature Reviews Drug Discovery

Fibroblast Growth Factor ResearchParathyroid Disorders and Treatments

Cited by 424

Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice

Degirolamo, C., Rainaldi, S., Bovenga, F., Murzilli, S., & Moschetta, A. (2014) · Cell Reports

Gut microbiota and healthDrug Transport and Resistance Mechanisms

Cited by 356

Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation

Degirolamo, C., Modica, S., Vacca, M., Di Tullio, G., Morgano, A., D'Orazio, A., Kannisto, K., Parini, P., & Moschetta, A. (2015) · Hepatology

Drug Transport and Resistance MechanismsCholesterol and Lipid Metabolism

Cited by 121

Dietary monounsaturated fatty acids appear not to provide cardioprotection.

Degirolamo, C., & Rudel, L. L. (2010) · Current Atherosclerosis Reports

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 72

LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat

Degirolamo, C., Shelness, G. S., & Rudel, L. L. (2009) · Journal of Lipid Research

Fatty Acid Research and HealthCholesterol and Lipid Metabolism

Cited by 58